Advanced Therapeutics Pharmaceutical Outsourcing Market Size Reaches $8.82 Billion In 2026: What Is Driving Growth?
Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Advanced Therapeutics Pharmaceutical Outsourcing Market Poised To Hit $10.73 Billion By 2030 With A 5% CAGR
The market size for advanced therapeutics pharmaceutical outsourcing has consistently expanded in recent years. It is projected to increase from $8.41 billion in 2025 to $8.82 billion in 2026, displaying a compound annual growth rate (CAGR) of 5.0%. The historical growth observed in this period can be ascribed to a rising biologics pipeline, the significant cost of in-house manufacturing, the increasing prevalence of oncology and rare diseases, a scarcity of internal expertise in advanced therapies, and the globalization of clinical trials.
The advanced therapeutics pharmaceutical outsourcing market is anticipated to experience substantial expansion over the upcoming years. Its valuation is projected to reach $10.73 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.0%. This growth during the projected period stems from several factors, including the rising adoption of personalized medicine, the broadening of commercial-scale cell and gene therapies, heightened regulatory complexity, an influx of funding for biotech startups, and the imperative for quicker market entry. Key developments expected during the forecast timeframe encompass a greater reliance on outsourcing for cell and gene therapy production, an escalating need for comprehensive CDMO services, the development of advanced viral vector production capacities, an intensified emphasis on adhering to regulatory and quality standards, and more rapid outsourcing of clinical trials for uncommon and intricate conditions.
Get A Free Sample Report With In-Depth Market Insights:
Advanced Therapeutics Pharmaceutical Outsourcing Market Growth Factors: What’s Supporting Expansion?
The advanced therapeutics pharmaceutical outsourcing market is expected to experience growth driven by the increasing integration of cell and gene therapies. These therapies are cutting-edge treatments that utilize living cells or genetic material to treat or cure illnesses. The application of advanced therapeutics pharmaceutical outsourcing in cell and gene therapies provides companies with access to providers boasting proven track records and experienced personnel, thereby saving valuable time and resources typically spent on team development. For example, in March 2024, IQVIA Holdings Inc., a US-based provider of advanced analytics, technology solutions, and clinical research services for the life sciences and healthcare industries, reported that global spending on cell and gene therapies rose to $5.9 billion in 2023, marking a 38% increase from 2022. Consequently, the expanding adoption of cell and gene therapies is a significant factor propelling the growth of the advanced therapeutics pharmaceutical outsourcing market.
Advanced Therapeutics Pharmaceutical Outsourcing Market Segment Landscape: Which Areas Lead Development?
The advanced therapeutics pharmaceutical outsourcing market covered in this report is segmented –
1) By Service Type: Contract Research Organizations (CROs), Contract Development And Manufacturing Organizations (CDMOs)
2) By Indication: Oncology, Neurology, Other Indications
3) By Therapy: Cell Therapy, Gene Therapy, RNA-based Therapies
4) By Application: Preclinical Services, Clinical Services, Commercial Manufacturing And Packaging
Subsegments:
1) By Contract Research Organizations (CROs): Preclinical Research Services, Clinical Trial Management Services, Regulatory Affairs Services, Data Management And Biostatistics
2) By Contract Development And Manufacturing Organizations (CDMOs): Drug Development Services, Formulation Development, Analytical Testing Services, Commercial Manufacturing Services
Advanced Therapeutics Pharmaceutical Outsourcing Market Industry Trends: What’s Reshaping Demand?
Leading firms within the advanced therapeutics pharmaceutical outsourcing sector are prioritizing strategic alliances to ensure dependable service delivery to their clientele. Such a partnership represents a collaborative agreement between usually two or more businesses, established to attain shared objectives that individual partners would be unable to reach on their own. As an illustration, Lonza, a manufacturing enterprise based in Switzerland serving the pharmaceutical, biotechnology, and nutrition industries, formed an alliance in January 2023 with Context Therapeutics Inc., a US-based biopharmaceutical firm dedicated to developing treatments for solid tumors. This collaboration entails Lonza undertaking manufacturability evaluations, gene and cell line engineering, and process optimization for both the drug substance and the final drug product.
Advanced Therapeutics Pharmaceutical Outsourcing Market Industry Leaders And Competitive Landscape
Major companies operating in the advanced therapeutics pharmaceutical outsourcing market are Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, IQVIA, ICON plc, SGS SA, Lonza Group, Parexel International Corporation, WuXi AppTec, Syneos Health, Catalent Inc., Charles River Laboratories International, Recipharm AB, Samsung Biologics, Vetter Pharma International GmbH, Medpace Holdings Inc., Fujifilm Diosynth Biotechnologies, AGC Biologics, Evotec SE, Piramal Pharma Solutions, Corden Pharma International LLC, Novotech Pty Ltd., Cytovance Biologics
View The Full Advanced Therapeutics Pharmaceutical Outsourcing Market Report:
Advanced Therapeutics Pharmaceutical Outsourcing Market Geographic Distribution And Regional Opportunities
North America was the largest region in the advanced therapeutics pharmaceutical outsourcing market in 2025. The regions covered in the advanced therapeutics pharmaceutical outsourcing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
